{ "items": [ "\n\n
\n \n 15 February 2024\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nNew research by NDM, the Radcliffe Department of Medicine, the MRC Translational Immune Discovery Unit and University of Cambridge research groups, has uncovered how antibodies trigger immune receptors in T cells. This breakthrough provides an improved framework for designing therapeutic antibodies, which could be used in new and better therapies for cancer and autoimmune diseases.
\n \n\n\n \n 13 February 2024\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nA recent study by the Medicine Quality Research Group found that during the pandemic there was a surge in low-quality COVID-19 medical products globally, including substandard and counterfeit medicines, diagnostics, PPE, sanitisers, and vaccines.
\n \n\n\n \n 12 February 2024\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nA team of researchers at NDM\u2019s Oxford University Clinical Research Unit (OUCRU) has pioneered a novel, microbiological assay-independent diagnostic model for adult Tuberculous Meningitis, leveraging Bayesian latent class analysis to improve the accuracy of diagnoses. This innovative approach, promises to enhance the detection and treatment of one of the most severe forms of tuberculosis (TB).
\n \n\n\n \n 8 February 2024\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe AI-driven Structure-enabled Antiviral Platform (ASAP) has won an Exemplary Achievement Award from the Federation of American Societies for Experimental Biology (FASEB) and the National Institutes of Health (NIH). The prize recognises data practices in biological and biomedical research labs during the active phase of research.
\n \n\n\n \n 6 February 2024\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe University of Oxford has entered into an agreement with three Brazilian universities, to contribute to the delivery of an undergraduate course in \u2018Translational Science\u2019, starting in 2024. The course will teach the full journey of a product \u2018from bench to bedside\u2019 as part of any science degree to prepare the next generation of researchers for the translation of their laboratory discoveries into patient care and prevention.
\n \n\n\n \n 5 February 2024\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nThe phase III trial data results of the R21/Matrix-M vaccine, developed by the Jenner Institute and the Serum Institute of India have confirmed high efficacy and supported regulatory approvals and licensure in several African countries.
\n \n\n\n \n 2 February 2024\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nThe largest multiparameter immunoprofiling study in cancer to date has suggested an underappreciated role of a subset of immune cells in determining the risk of bowel cancer relapse after surgery.
\n \n\n\n \n 30 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nA new hepatitis B study reveals how viruses adapt to low-oxygen environments, such as those found deep within the liver, opening up possible new therapeutic targets for liver pathogens. NDM researchers have identified hypoxia-inducible factors (HIFs) playing an important role in the regulation of editing of viral RNAs in low oxygen conditions.
\n \n\n\n \n 29 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers at the Jenner Institute, the Oxford Vaccine Group and the Pandemic Sciences Institute hosted the Rt Hon Andrew Mitchell MP, Minister for Development and Africa, to the laboratories and clinics of several of its vaccine development groups.
\n \n\n\n \n 25 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Big Data Institute along with the collaborators have developed a new, easy-to-use technique for hospitals to contribute to developing artificial intelligence (AI) models, without patient data leaving the hospital\u2019s premises.
\n \n\n\n \n 23 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nA recent study by the Mahidol-Oxford Tropical Medicine Research Unit (MORU) at NDM outlined a highly effective method for dengue surveillance. The researchers improved risk detection in real time by combining space-time modelling and anomaly detection. This will help in making dengue prevention more effective not only in Thailand but also in other regions with similar challenges.
\n \n\n\n \n 19 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nA recent study by NDM\u2019s Mahidol Oxford Tropical Medicine Research Unit researchers highlighted that there was no difference in the rate of viral clearance between patients given Favipiravir and patients receiving no study drug.
\n \n\n\n \n 18 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nA recent study led by the Centre for Human Genetics at NDM has revealed that areas of the human genome that are routinely overlooked in clinical tests may be the cause of some rare diseases.
\n \n\n\n \n 17 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers from a wide range of disciplines have been appointed to be the next cohort of NIHR Oxford Senior Research Fellows - seven mid-career researchers identified as having the potential to become future translational research leaders. The cohort includes Dr Matthias Friedrich from the Translational Gastroenterology Unit in NDM\u2019s Experimental Medicine Division.
\n \n\n\n \n 16 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Jenner Institute at NDM is conducting a new study using the Bacille Calmette-Gu\u00e9rin (BCG) vaccine, the only vaccine currently licensed against tuberculosis. People who have received the BCG vaccine previously will be given it again to compare whether giving it by inhalation is better at protecting people against tuberculosis than giving it through the skin.
\n \n\n\n \n 15 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nA new study by researchers from the Ethox Centre and NDM has highlighted important ethical considerations in Nipah virus outbreak control, its treatment, and research into vaccines.
\n \n\n\n \n 12 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nA teledermatology initiative by Oxford University Clinical Research Unit (OUCRU) Indonesia, in partnership with the Sumba Foundation and Gadjah Mada University, has made significant strides in transforming rural healthcare in Eastern Indonesia.
\n \n\n\n \n 11 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe first clinical trial participants received doses of the ChAdOx1 NipahB vaccine this week at the University of Oxford. This is the first-in-human trial of the vaccine, being developed by researchers at the Pandemic Sciences Institute.
\n \n\n\n \n 9 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nIn a recent study, NDM\u2019s Mahidol Oxford Tropical Medicine Research Unit (MORU) researchers introduced an anomaly detection system, as an early warning mechanism for potential malaria outbreaks in countries like Thailand.
\n \n\n\n \n 5 January 2024\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers from the Mahidol Oxford Tropical Medicine Research Unit at NDM, in a recent study, analysed the uptake of community health workers' services and the effectiveness of this programme in controlling and eliminating malaria.
\n \n\n